Table 2.
Time | Time | |||
---|---|---|---|---|
Stimulation/antagonist | control (1) | control (2) | Control | Antagonist |
NMDA (100 mM) spritz/APV (100 μM) | 65 | 54/65 | 57 | 37/57∗ |
L-Glu (50 mM) spritz/APV (500 μM) | 54 | 47/54 | 30 | 19/30∗ |
1 pulse/APV (500 μM) | 27 | 14/27 | 21 | 14/21 |
20 pulse/APV (500 μM) | 41 | 29/41 | 27 | 17/27 |
L-Glu (50 mM) spritz/CNQX (20 μM) | 25 | 18/25 | 38 | 30/38 |
L-Glu (50 mM) spritz/PHCCC (30 μM) | 75 | 60/75 | 61 | 41/61 |
1 pulse/PHCCC (30 μM) | 35 | 24/35 | 37 | 15/37 |
20/PHCCC (30μM) | 62 | 56/62 | 50 | 37/50∗ |
∗P < 0.05 Fisher’s Exact Test.